10.15.26 -- Misconceptions And Metrics Of A Proactive CCS Strategy

Master the complexities of aseptic gowning and Annex 1 compliance. Explore risk-based strategies to mitigate human-source contamination and strengthen your facility's sterility assurance.

Optimize vaccine production with integrated manufacturing, analytical testing, containment solutions, and automated inspection for efficient, reliable scale-up.

Test multiple samples at once with a multi‑sample testing platform that ensures accurate detection for low headspace formats and integrates into automated lines for high-volume efficiency.

In this segment from the Pharmaceutical Online Live event, our panelists talk about misconceptions when it comes to CCS strategy, what proactive actually looks like operationally, and the metrics that validate the CCS strategy is effective.

Discover how hidden material transfer vulnerabilities compromise cleanroom sterility, as well as how to identify upstream storage risks and implement mechanical wiping techniques to fortify your facility.

Combining denaturing and native analytical techniques reveals molecular weight impurities in mAbs, delivering a more complete and reliable purity profile that supports confident decisions.